Eligibility Criteria for Ferric Carboxymaltose in Women with Iron Deficiency in Obstetrics: An Algerian Expert Consensus

BACKGROUND: Iron deficiency (ID) and ID anemia (IDA) are widespread health issues affecting a significant number of women in Algeria, particularly during pregnancy. With a lack of clear, localized guidelines for managing ID and IDA in Algeria, the need for a consensus on the eligibility criteria for...

Full description

Saved in:
Bibliographic Details
Main Authors: Rachida Aouameur, Hafida Bendaoud, Ouafa Guellati, Amel Dammene-Debbih, Manar Lahmar, Nacera Benmouhoub, Zahra Farah, Hichem Makhloufi, Issam Frigaa, Fadela Madaci, Lamine Mahi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Journal of Applied Hematology
Subjects:
Online Access:https://journals.lww.com/10.4103/joah.joah_75_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550050355838976
author Rachida Aouameur
Hafida Bendaoud
Ouafa Guellati
Amel Dammene-Debbih
Manar Lahmar
Nacera Benmouhoub
Zahra Farah
Hichem Makhloufi
Issam Frigaa
Fadela Madaci
Lamine Mahi
author_facet Rachida Aouameur
Hafida Bendaoud
Ouafa Guellati
Amel Dammene-Debbih
Manar Lahmar
Nacera Benmouhoub
Zahra Farah
Hichem Makhloufi
Issam Frigaa
Fadela Madaci
Lamine Mahi
author_sort Rachida Aouameur
collection DOAJ
description BACKGROUND: Iron deficiency (ID) and ID anemia (IDA) are widespread health issues affecting a significant number of women in Algeria, particularly during pregnancy. With a lack of clear, localized guidelines for managing ID and IDA in Algeria, the need for a consensus on the eligibility criteria for ferric carboxymaltose (FCM) usage in obstetrics was recognized. AIMS AND OBJECTIVES: In this context, a national expert panel aimed to establish a consensus on the eligibility criteria for FCM as the optimal intravenous (IV) iron treatment for women with ID/IDA in obstetrics, based on shared experiences and insights. METHODS: The expert panel, comprising seven obstetricians and gynecologists, three anesthetists and intensive care specialists, and one hematologist, deliberated on the use of IV iron therapy, specifically FCM, in the field of obstetrics. RESULTS: The panel reached a consensus on serum ferritin cutoff levels, key diagnostic parameters for IDA, the role of C-reactive protein in IDA screening, and the need for harmonization with international guidelines. They also discussed the treatment of ID/IDA, including nutritional well-being, oral and IV iron therapy, and the indication of transfusion. Specific criteria for prescribing IV iron, especially FCM, to pregnant women were identified. CONCLUSION: This expert consensus represents a significant step toward improving the diagnosis and management of ID and IDA during pregnancy in Algeria. The recommendations emphasize the efficient and effective use of FCM as an IV treatment, enhancing the standard of care for obstetric patients.
format Article
id doaj-art-fc1553b1526b456fa8390856e77222d5
institution Kabale University
issn 1658-5127
2454-6976
language English
publishDate 2024-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Applied Hematology
spelling doaj-art-fc1553b1526b456fa8390856e77222d52025-01-10T11:14:19ZengWolters Kluwer Medknow PublicationsJournal of Applied Hematology1658-51272454-69762024-12-0115429430010.4103/joah.joah_75_24Eligibility Criteria for Ferric Carboxymaltose in Women with Iron Deficiency in Obstetrics: An Algerian Expert ConsensusRachida AouameurHafida BendaoudOuafa GuellatiAmel Dammene-DebbihManar LahmarNacera BenmouhoubZahra FarahHichem MakhloufiIssam FrigaaFadela MadaciLamine MahiBACKGROUND: Iron deficiency (ID) and ID anemia (IDA) are widespread health issues affecting a significant number of women in Algeria, particularly during pregnancy. With a lack of clear, localized guidelines for managing ID and IDA in Algeria, the need for a consensus on the eligibility criteria for ferric carboxymaltose (FCM) usage in obstetrics was recognized. AIMS AND OBJECTIVES: In this context, a national expert panel aimed to establish a consensus on the eligibility criteria for FCM as the optimal intravenous (IV) iron treatment for women with ID/IDA in obstetrics, based on shared experiences and insights. METHODS: The expert panel, comprising seven obstetricians and gynecologists, three anesthetists and intensive care specialists, and one hematologist, deliberated on the use of IV iron therapy, specifically FCM, in the field of obstetrics. RESULTS: The panel reached a consensus on serum ferritin cutoff levels, key diagnostic parameters for IDA, the role of C-reactive protein in IDA screening, and the need for harmonization with international guidelines. They also discussed the treatment of ID/IDA, including nutritional well-being, oral and IV iron therapy, and the indication of transfusion. Specific criteria for prescribing IV iron, especially FCM, to pregnant women were identified. CONCLUSION: This expert consensus represents a significant step toward improving the diagnosis and management of ID and IDA during pregnancy in Algeria. The recommendations emphasize the efficient and effective use of FCM as an IV treatment, enhancing the standard of care for obstetric patients.https://journals.lww.com/10.4103/joah.joah_75_24algeriaferric carboxymaltoseiron deficiencyiron deficiency anemiapregnancy
spellingShingle Rachida Aouameur
Hafida Bendaoud
Ouafa Guellati
Amel Dammene-Debbih
Manar Lahmar
Nacera Benmouhoub
Zahra Farah
Hichem Makhloufi
Issam Frigaa
Fadela Madaci
Lamine Mahi
Eligibility Criteria for Ferric Carboxymaltose in Women with Iron Deficiency in Obstetrics: An Algerian Expert Consensus
Journal of Applied Hematology
algeria
ferric carboxymaltose
iron deficiency
iron deficiency anemia
pregnancy
title Eligibility Criteria for Ferric Carboxymaltose in Women with Iron Deficiency in Obstetrics: An Algerian Expert Consensus
title_full Eligibility Criteria for Ferric Carboxymaltose in Women with Iron Deficiency in Obstetrics: An Algerian Expert Consensus
title_fullStr Eligibility Criteria for Ferric Carboxymaltose in Women with Iron Deficiency in Obstetrics: An Algerian Expert Consensus
title_full_unstemmed Eligibility Criteria for Ferric Carboxymaltose in Women with Iron Deficiency in Obstetrics: An Algerian Expert Consensus
title_short Eligibility Criteria for Ferric Carboxymaltose in Women with Iron Deficiency in Obstetrics: An Algerian Expert Consensus
title_sort eligibility criteria for ferric carboxymaltose in women with iron deficiency in obstetrics an algerian expert consensus
topic algeria
ferric carboxymaltose
iron deficiency
iron deficiency anemia
pregnancy
url https://journals.lww.com/10.4103/joah.joah_75_24
work_keys_str_mv AT rachidaaouameur eligibilitycriteriaforferriccarboxymaltoseinwomenwithirondeficiencyinobstetricsanalgerianexpertconsensus
AT hafidabendaoud eligibilitycriteriaforferriccarboxymaltoseinwomenwithirondeficiencyinobstetricsanalgerianexpertconsensus
AT ouafaguellati eligibilitycriteriaforferriccarboxymaltoseinwomenwithirondeficiencyinobstetricsanalgerianexpertconsensus
AT ameldammenedebbih eligibilitycriteriaforferriccarboxymaltoseinwomenwithirondeficiencyinobstetricsanalgerianexpertconsensus
AT manarlahmar eligibilitycriteriaforferriccarboxymaltoseinwomenwithirondeficiencyinobstetricsanalgerianexpertconsensus
AT nacerabenmouhoub eligibilitycriteriaforferriccarboxymaltoseinwomenwithirondeficiencyinobstetricsanalgerianexpertconsensus
AT zahrafarah eligibilitycriteriaforferriccarboxymaltoseinwomenwithirondeficiencyinobstetricsanalgerianexpertconsensus
AT hichemmakhloufi eligibilitycriteriaforferriccarboxymaltoseinwomenwithirondeficiencyinobstetricsanalgerianexpertconsensus
AT issamfrigaa eligibilitycriteriaforferriccarboxymaltoseinwomenwithirondeficiencyinobstetricsanalgerianexpertconsensus
AT fadelamadaci eligibilitycriteriaforferriccarboxymaltoseinwomenwithirondeficiencyinobstetricsanalgerianexpertconsensus
AT laminemahi eligibilitycriteriaforferriccarboxymaltoseinwomenwithirondeficiencyinobstetricsanalgerianexpertconsensus